NLRP3 and cholangiocarcinoma: Besides immune cells, NLRP3 component of inflammasome is expressed in biliary epithelial cells in primary sclerosing cholangitis, and its lower expression during time and insufficient signaling may be associated with the development of cholangiocarcinoma [159].